Related Experiment Video
Updated: Jun 24, 2026

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
Published on: April 1, 2019
Dry eye symptoms in children: can we reliably measure them?
Ngozi Charity Chidi-Egboka1, Blanka Golebiowski1, Sun-Young Lee1
1School of Optometry and Vision Science, UNSW, Sydney, NSW, 2052, Australia.
Insights
Pediatric dry eye questionnaires are feasible and repeatable in children aged 6-15. The Dry Eye Questionnaire 5 (DEQ-5) and Instant Ocular Symptoms Survey (IOSS) are recommended for younger children.
Area of Science:
- Ophthalmology
- Pediatric Eye Care
- Clinical Research
Background:
- Dry eye is a common condition affecting children.
- Existing dry eye questionnaires may not be suitable for pediatric populations.
- Assessing dry eye symptoms in children requires validated and reliable tools.
Purpose of the Study:
- To evaluate the feasibility and repeatability of various dry eye questionnaires in children aged 6-15.
- To determine the suitability of different symptom questionnaires for pediatric dry eye assessment.
- To identify age-appropriate questionnaires for use in pediatric eye care.
Main Methods:
- Sixty-two participants (aged 6-15) completed six dry eye questionnaires twice.
- Questionnaires included SANDE, OSDI, NRS, OCI, DEQ-5, and IOSS.
- Completion time, need for assistance, repeatability (CoR, ICC), and age-related differences were analyzed.
Main Results:
- All questionnaires were completed in under 2 minutes.
- Younger children required more time and assistance.
- DEQ-5 and IOSS showed better suitability for younger children, with moderate to excellent repeatability (ICC).
Conclusions:
- Dry eye questionnaires are reliable for pediatric eye care.
- Younger children may need more time and assistance.
- DEQ-5 and IOSS are recommended for assessing dry eye symptoms in younger pediatric patients.
Purpose:
Many dry eye questionnaires are available, but these may not be suitable for paediatric eye care. The feasibility of use and repeatability of symptom questionnaires administered to children was examined.
Methods:
Participants aged 6-15 years (n = 62; 25M:37F; 40% male) completed six questionnaires twice in random order at a single visit: Symptoms assessment in dry eye (SANDE), ocular surface disease index (OSDI), numerical rating scale (NRS), ocular comfort index (OCI, n = 30), dry eye questionnaire 5 (DEQ-5) and the instant ocular symptoms survey (IOSS). Completion time and need for assistance were recorded and relationships with age examined (Pearson correlation, independent t-test). The number of participants requiring assistance and with which items were compared (linear mixed model, pairwise test). Repeatability (coefficient of repeatability (CoR), limit of agreement, bias) and intraclass correlation coefficient (ICC) were examined.
Results:
Completion time was ≤2 min for each individual questionnaire. Younger participants took longer to complete (r = -0.43 to -0.60, p ≤ 0.01), and required more assistance (p ≤ 0.001). Forty-eight participants required assistance with at least one questionnaire. Older children (13-15 years) only required assistance with OSDI (p ≤ 0.004) and NRS (p ≤ 0.003). Participants required more assistance with SANDE, OSDI and NRS than with DEQ-5 and IOSS (p ≤ 0.02) and with gritty (OSDI, 77% of participants; OCI, 100%) and foreign body sensation (NRS, 92%) items. CoR was similar for all questionnaires with no evidence of a learning effect (p > 0.05). ICC was moderate to excellent.
Conclusions:
Dry eye questionnaires can be used reliably in paediatric eye care; more time and assistance may be required for younger children. The DEQ-5 and IOSS are recommended for use in younger age children.
More Related Videos
08:04A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies
Published on: January 24, 2020
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Related Concept Videos
Accessory Structures of the Eye
Ophthalmic Drug Delivery Systems